The American Society for Transplantation and Cellular Therapy is an international professional membership association of more than 3,700 physicians, investigators and other health care professionals from more than 50 countries. Our mission is dedicated to improving the application and success of hematopoietic cell transplantation and related cellular therapies. We strive to be the leading organization promoting research, education and clinical practice in the field.
The Tandem Meetings Transplantation & Cellular Therapy Meetings of ASTCT® and CIBMTR®, will take place February 12–15, 2025 | Hawai‘i Convention Center, Honolulu, HI. The Tandem Meetings are the premier not-for-profit event in the evolving field of hematopoietic cell transplantation and cellular therapy. Through the scientific program, attendees gain access to the latest scientific updates, new technologies and innovative products in hematopoietic cell transplantation and cellular therapy.
Stay Informed:
Explore the latest scientific updates, emerging technologies, and groundbreaking products that are shaping the future of hematopoietic cell transplantation and cellular therapy.
Global Perspectives:
Connect with leading international experts who will share invaluable insights, case studies, and results that are driving advancements in the treatment of patients with blood-related disorders.
Join a Collaborative Community:
Immerse yourself in a collaborative community of healthcare professionals from around the world. Discover unique opportunities to engage, share knowledge, and contribute to the collective progress in the field.
Invest in Your Professional Growth:
Take advantage of our platform to earn continuing medical, pharmacy, and nursing education credits. Elevate your career by staying at the forefront of the latest developments in hematopoietic cell transplantation and cellular therapy.
The Tandem Meetings foster innovation, collaboration, and continuous learning in the pursuit of improved patient outcomes. Join us on the frontier of medical science and be a part of the evolution in hematopoietic cell transplantation and cellular therapy.
